Video Shorts

Thomas Powles, MD, MBBS, MRCP, Barts Cancer Centre
0:44
Exploring ctDNA Dynamics in the IMvigor011 Trial
7 months ago
by
Thomas Powles, MD, MBBS, MRCP
Unpacking the Final Data From SunRISe-2
0:53
Unpacking the Final Data From SunRISe-2
7 months ago
by
Andrea Necchi, MD
Top ASCO GU 2026 Abstracts According to Fellows
0:46
Top ASCO GU 2026 Abstracts According to Fellows
7 months ago
by
Riley Kandel
Igor Makhlin, MD
0:45
Imaging Modalities for Metastatic Breast Cancer Diagnosis and Staging
7 months ago
by
Igor Makhlin, MD
Rising Stars in GU Oncology Share New Data at OncLive Fellows Forum
1:30
Rising Stars in GU Oncology Share New Data at OncLive Fellows Forum
7 months ago
by
Riley Kandel
Arshed Al-Obeidi, MD
1:25
Examining Alternative Splicing in Metastatic Bladder Cancer
7 months ago
by
Arshed Al-Obeidi, MD
Akshit Chitkara, MD
0:52
Sarcomatoid vs Rhabdoid Dedifferentiation Outcomes in mccRCC
7 months ago
by
Akshit Chitkara, MD
Jason Westin, MD, explains the rationale for the ongoing evaluation of the novel CELMoD golcadomide (CC-99282) in the management of large B-cell lymphoma.
0:57
The Exploration of Golcadomide in LBCL Management
7 months ago
by
Jason Westin, MD
Tycel Phillips, MD
0:59
Important Upcoming Clinical Trials to Watch For in MCL
7 months ago
by
Tycel Phillips, MD
Ashkan Emadi, MD, PhD
0:57
Subcutaneous Blinatumomab Demonstrates Promising Efficacy and Safety in First Patient With MPAL
7 months ago
by
Ashkan Emadi, MD, PhD
Real-World Data for Luspatercept in Lower-Risk MDS
2:36
Real-World Data for Luspatercept in Lower-Risk MDS
7 months ago
by
Amer Zeidan, MBBS, MD
Guillermo Garcia-Manero, MD, breaks down the implications of the negative phase 3 VERONA trial in higher-risk MDS.
0:47
Implications of the Negative VERONA Trial of Venetoclax/Azacitidine in Higher-Risk MDS
7 months ago
by
Guillermo Garcia-Manero, MD
Vincent Picozzi, MD
0:41
First TTFields Approval in Pancreatic Cancer Paves Way for More Multimodal Approaches
7 months ago
by
Vincent J. Picozzi, MD
Maurie Markman, MD
1:46
Understanding the Therapeutic Team Delivery Concept in Oncology
7 months ago
by
Maurie Markman, MD
Lisa Zhang, MD
0:59
Reexamining the Definition of Postpartum Breast Cancer
7 months ago
by
Lisa Zhang, MD
OncLive News Roundup for the Week of 2/15
3:41
OncLive News Roundup for the Week of 2/15
7 months ago
by
Courtney Flaherty(+1 more)
Joel Neal, MD, PhD
1:35
Evolving Frontline Treatment Options in EGFR-Mutated NSCLC
7 months ago
by
Joel Neal, MD, PhD
Sara Tolaney, MD, MPH
1:41
Expert Insight on FDA Approval of T-DXd Plus Pertuzumab in HER2+ Breast Cancer
7 months ago
by
Riley Kandel
Sagar Lonial, MD, FACP, FASCO on CELMoDs in Multiple Myeloma
1:10
The Evaluation of CELMoDs in Multiple Myeloma
7 months ago
by
Sagar Lonial, MD, FACP, FASCO
Reva K. Basho, MD
0:49
Highlighting the Potential Implications of the Ongoing INAVO123 Trial in HR+ Breast Cancer
7 months ago
by
Reva K. Basho, MD
Anwar Saeed, MD
0:59
STELLAR-303 Paves the Way for Potential FDA Approval of Immunotherapy-Based Regimen in MSS CRC
7 months ago
by
Anwaar Saeed, MD
Matthew Hadfield, DO
1:32
Deconstructing Clinical Trial Interpretation for Fellows
7 months ago
by
Matthew Hadfield, DO
Linda Vahdat, MD, MBA
0:23
Starving Breast Cancer of Copper to Stop Disease From Spreading
7 months ago
by
Linda Vahdat, MD, MBA
David Rimm, MD, PhD
0:25
Highlighting the Role of Pathologists in Breast Cancer Care
7 months ago
by
David L. Rimm, MD, PhD
Vikram C. Gorantla, MD
0:31
The Importance of Patient Selection for Breast Cancer Treatment Optimization
7 months ago
by
Vikram C. Gorantla, MD
Ana Velázquez Mañana, MD, MSc, FASCO
1:10
Boosting Gender Equity in the Oncology Workforce
7 months ago
by
Ana Velázquez Mañana, MD, MSc, FASCO
Maurie Markman, MD
1:42
Tracing the Evolution of Multidisciplinary Cancer Care
7 months ago
by
Maurie Markman, MD
TCT 2026
1:10
Go Behind-the-Scenes With OncLive at TCT 2026
7 months ago
by
Courtney Flaherty
Martha Welman, MD
0:44
Reducing Time to Breast Cancer Screening and Diagnosis
7 months ago
by
Martha Welman, MD
Exploring the Significance of a Pembrolizumab-Based Regimen in Ovarian Cancer
0:41
Exploring the Significance of a Pembrolizumab-Based Regimen in Ovarian Cancer
7 months ago
by
Emese Zsiros, MD, PhD